Sign in
Not yet recruitingNo phase

Efficacy and Mechanisms of Time-Domain Interferential Transcranial Electrical Stimulation in Treating Depression Associated With Childhood Trauma

Key facts

Who runs it
Shanghai Mental Health Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
74 people, planned
Starts
18 Dec 2026
Expected to end
31 Dec 2028
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Active Transcranial Temporal Interference (TI) Stimulation
  • Sham Transcranial Temporal Interference (TI) Stimulation
  • Escitalopram Oxalate Medication
Record updated
17 November 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Aged 18-65 years
  • Meet ICD-11 diagnostic criteria for depressive episode
  • HAMD-17 score ≥17 and <25
  • History of childhood trauma assessed by the Childhood Trauma Questionnaire-Short Form (CTQ-SF), with at least one subscale meeting the protocol-defined threshold
  • At least junior high school education and able to complete self-report scales
  • No psychiatric medication within 1 month before enrollment
  • Able to provide informed consent

Who cannot take part

  • Severe cardiac, hepatic, or renal disease
  • Organic brain disease or severe neurological disorders
  • Severe cardiovascular disease, tumor, hematologic disease, rheumatic disease, malnutrition, or neurodegenerative disease
  • Depressive episode secondary to other psychiatric or physical disorders
  • Tobacco, alcohol, or other psychoactive substance abuse
  • Pregnancy
  • Participation in another clinical trial before enrollment

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Efficacy and Mechanisms of Time-Domain Interferential Transcranial Electrical Stimulation in Treating Depression Associated with Childhood Trauma Major depressive disorder (MDD) is a prevalent mental illness characterized by high suicide rates and substantial social burden. According to the World Health Organization's (WHO) Global Health Assessment Report on Depression, the global prevalence of MDD reached 350 million cases in 2021, making it the second leading cause of death among individuals aged 15-29 years. MDD is defined by core symptoms of persistent low mood and anhedonia, often accompanied by cognitive, behavioral, and physiological disturbances. These symptoms significantly impair individuals' daily functioning, social interactions, and occupational performance, and some patients may even engage in self-harm or suicidal behaviors[1,2]. MDD imposes a heavy burden on global disease burden, as well as on affected individuals, their families, and society at large.

Read full original descriptionShow less

Existing studies have identified childhood trauma as a major risk factor for MDD. Epidemiological research indicates that individuals who experience childhood trauma face a higher risk of developing MDD, anxiety disorders, or comorbid conditions. Childhood trauma may account for 28.9% of all mental disorders, exerting a lifelong impact on physical and mental health. Notably, 45.59% of MDD patients have a history of at least one type of childhood trauma. Adults with a history of childhood trauma are 2.66-3.73 times more likely to develop MDD compared to those without such experiences.

Animal studies suggest that environmental stress can induce depression-like behaviors in adolescent female rats, accompanied by elevated levels of corticosterone (CORT) and cholecystokinin (CCK), as well as reduced neuropeptide Y (NPY) expression[3,4,5,6]. However, there are currently no effective and safe pharmacological treatments for childhood trauma in clinical practice, and the overall quality of existing evidence remains low. While psychological interventions have been shown to reduce depressive symptoms in MDD patients with childhood trauma, the supporting evidence from evidence-based medicine is insufficient. Therefore, effective, non-pharmacological, well-tolerated, and accessible treatment modalities are crucial for managing MDD complicated by childhood trauma. Research has explored the underlying physiological mechanisms of childhood trauma from perspectives including neuroendocrinology, neuroinflammation, and neuroimaging, but a clear and comprehensive explanation remains elusive.

Temporal interference (TI) electrical stimulation is an emerging non-invasive brain stimulation technique. It utilizes two high-frequency carrier waves to generate low-frequency envelope oscillations in deep brain regions, enabling precise targeted modulation of subcortical structures such as the basal ganglia. Preliminary studies have demonstrated the potential clinical efficacy of TI in treating depression and trauma-related disorders. This paper reviews the research progress and future prospects of TI electrical stimulation in the management of MDD with childhood trauma.

The 2 groups in the trial

  • Experimental Group (Active TI Stimulation + Medication Group)Treatment being tested

    Treatment: Active Transcranial Temporal Interference (TI) Stimulation and Escitalopram Oxalate Medication

  • Control Group (Sham TI Stimulation + Medication Group)Sham treatment, for comparison

    Treatment: Sham Transcranial Temporal Interference (TI) Stimulation and Escitalopram Oxalate Medication

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT07941687, who can take part
Record updated
17 November 2026